vs
Side-by-side financial comparison of Dexcom (DXCM) and WEBSTER FINANCIAL CORP (WBS). Click either name above to swap in a different company.
Dexcom is the larger business by last-quarter revenue ($1.3B vs $735.9M, roughly 1.7× WEBSTER FINANCIAL CORP). WEBSTER FINANCIAL CORP runs the higher net margin — 33.5% vs 21.2%, a 12.2% gap on every dollar of revenue. Over the past eight quarters, Dexcom's revenue compounded faster (12.0% CAGR vs 9.4%).
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.
Webster Bank is an American commercial bank based in Stamford, Connecticut. It has 177 branches and 316 ATMs located in Connecticut; Massachusetts; Rhode Island; New Jersey; Westchester, Orange, Ulster, and Rockland counties in New York as well as New York City.
DXCM vs WBS — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.3B | $735.9M |
| Net Profit | $267.3M | $246.2M |
| Gross Margin | 62.9% | — |
| Operating Margin | 25.6% | — |
| Net Margin | 21.2% | 33.5% |
| Revenue YoY | 21.6% | — |
| Net Profit YoY | 153.6% | 8.5% |
| EPS (diluted) | $0.67 | $1.50 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.3B | $735.9M | ||
| Q4 25 | $1.3B | $746.2M | ||
| Q3 25 | $1.2B | $732.6M | ||
| Q2 25 | $1.2B | $715.8M | ||
| Q1 25 | $1.0B | $704.8M | ||
| Q4 24 | $1.1B | $661.0M | ||
| Q3 24 | $994.2M | $647.6M | ||
| Q2 24 | $1.0B | $614.6M |
| Q1 26 | $267.3M | $246.2M | ||
| Q4 25 | $267.3M | $255.8M | ||
| Q3 25 | $283.8M | $261.2M | ||
| Q2 25 | $179.8M | $258.8M | ||
| Q1 25 | $105.4M | $226.9M | ||
| Q4 24 | $151.7M | $177.8M | ||
| Q3 24 | $134.6M | $193.0M | ||
| Q2 24 | $143.5M | $181.6M |
| Q1 26 | 62.9% | — | ||
| Q4 25 | 62.9% | — | ||
| Q3 25 | 60.5% | — | ||
| Q2 25 | 59.5% | — | ||
| Q1 25 | 56.9% | — | ||
| Q4 24 | 58.9% | — | ||
| Q3 24 | 59.7% | — | ||
| Q2 24 | 62.4% | — |
| Q1 26 | 25.6% | — | ||
| Q4 25 | 25.6% | 48.6% | ||
| Q3 25 | 20.1% | 51.3% | ||
| Q2 25 | 18.4% | 51.7% | ||
| Q1 25 | 12.9% | 51.2% | ||
| Q4 24 | 17.0% | 48.5% | ||
| Q3 24 | 15.3% | 46.1% | ||
| Q2 24 | 15.7% | 47.0% |
| Q1 26 | 21.2% | 33.5% | ||
| Q4 25 | 21.2% | 34.3% | ||
| Q3 25 | 23.5% | 35.7% | ||
| Q2 25 | 15.5% | 36.2% | ||
| Q1 25 | 10.2% | 32.2% | ||
| Q4 24 | 13.6% | 26.9% | ||
| Q3 24 | 13.5% | 29.8% | ||
| Q2 24 | 14.3% | 29.6% |
| Q1 26 | $0.67 | $1.50 | ||
| Q4 25 | $0.67 | $1.54 | ||
| Q3 25 | $0.70 | $1.54 | ||
| Q2 25 | $0.45 | $1.52 | ||
| Q1 25 | $0.27 | $1.30 | ||
| Q4 24 | $0.37 | $1.01 | ||
| Q3 24 | $0.34 | $1.10 | ||
| Q2 24 | $0.35 | $1.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $917.7M | — |
| Total DebtLower is stronger | — | $738.3M |
| Stockholders' EquityBook value | $2.7B | $9.6B |
| Total Assets | $6.3B | $85.6B |
| Debt / EquityLower = less leverage | — | 0.08× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $917.7M | — | ||
| Q4 25 | $917.7M | — | ||
| Q3 25 | $1.8B | — | ||
| Q2 25 | $1.2B | — | ||
| Q1 25 | $904.9M | — | ||
| Q4 24 | $606.1M | — | ||
| Q3 24 | $621.2M | — | ||
| Q2 24 | $939.2M | — |
| Q1 26 | — | $738.3M | ||
| Q4 25 | — | $739.5M | ||
| Q3 25 | — | $1.2B | ||
| Q2 25 | — | $905.6M | ||
| Q1 25 | — | $907.4M | ||
| Q4 24 | — | $909.2M | ||
| Q3 24 | — | $911.0M | ||
| Q2 24 | — | $912.7M |
| Q1 26 | $2.7B | $9.6B | ||
| Q4 25 | $2.7B | $9.5B | ||
| Q3 25 | $2.7B | $9.5B | ||
| Q2 25 | $2.6B | $9.3B | ||
| Q1 25 | $2.3B | $9.2B | ||
| Q4 24 | $2.1B | $9.1B | ||
| Q3 24 | $2.0B | $9.2B | ||
| Q2 24 | $2.4B | $8.8B |
| Q1 26 | $6.3B | $85.6B | ||
| Q4 25 | $6.3B | $84.1B | ||
| Q3 25 | $7.5B | $83.2B | ||
| Q2 25 | $7.3B | $81.9B | ||
| Q1 25 | $6.8B | $80.3B | ||
| Q4 24 | $6.5B | $79.0B | ||
| Q3 24 | $6.4B | $79.5B | ||
| Q2 24 | $6.8B | $76.8B |
| Q1 26 | — | 0.08× | ||
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.13× | ||
| Q2 25 | — | 0.10× | ||
| Q1 25 | — | 0.10× | ||
| Q4 24 | — | 0.10× | ||
| Q3 24 | — | 0.10× | ||
| Q2 24 | — | 0.10× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DXCM
Segment breakdown not available.
WBS
| Net Interest Income | $634.4M | 86% |
| Noninterest Income | $101.5M | 14% |
